Equinet-ag advice for BB Biotech
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| April 30, 2015 | Equinet-ag | BB Biotech | Buy | 288.00 CHF | 82.08 % |
Advice details
Frankfurt - Op 30 Apr 2015 herhalen de analisten van Equinet-ag hun koopadvies voor BB Biotech (ISIN: CH0038389992 / Mnemo: BBZ). Het 12-maands koersdoel wordt opwaarts bijgesteld van 196.0 CHF naar 288.0 CHF.
Back
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2025 ValueSpectrum. All Rights Reserved
Developed and maintained by 